![Greg Gocal](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Greg Gocal
Gründer bei
CALYXT, INC.
Vermögen: 579 359 $ am 30.06.2026
Profil
Dr. Greg Gocal is a Chief Scientific Officer & Executive VP at Cibus Corp., a Chief Scientific Officer & Executive VP at Cibus, Inc., a Chief Scientific Officer at Cibus US LLC and a Chief Scientific Officer & Executive VP at Cibus Ltd. Dr. Gocal was previously employed as a Principal by CSIRO's ICT Sector Advisory Council, a Principal by The Salk Institute for Biological Studies, and a Principal by Valigen NV.
He received his undergraduate degree from the University of Calgary, a graduate degree from the University of Calgary and a doctorate degree from The Australian National University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 24.04.2026 | 422’890 ( 0.8% ) | 579 359 $ | 30.06.2026 |
Aktive Positionen von Greg Gocal
| Unternehmen | Position | Beginn |
|---|---|---|
| CALYXT, INC. | Gründer | 01.01.2001 |
| CALYXTPAR | Gründer | 01.01.2001 |
Cibus US LLC
 Cibus US LLC BiotechnologyHealth Technology Develops products in agriculture and specialty chemicals | Technik-/Wissenschafts-/F&E-Leiter | - |
Cibus Ltd.
 Cibus Ltd. BiotechnologyHealth Technology Engages in the research and development of plant gene editing technology | Technik-/Wissenschafts-/F&E-Leiter | - |
Ehemalige bekannte Positionen von Greg Gocal
| Unternehmen | Position | Ende |
|---|---|---|
CSIRO's ICT Sector Advisory Council | Corporate Officer/Principal | - |
The Salk Institute for Biological Studies
 The Salk Institute for Biological Studies Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Valigen NV
 Valigen NV Miscellaneous Commercial ServicesCommercial Services Perform genotyping and functional genomics | Corporate Officer/Principal | - |
Ausbildung von Greg Gocal
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
29
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
The Salk Institute for Biological Studies
The Salk Institute for Biological Studies Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cibus Corp.
 Cibus Corp. BiotechnologyHealth Technology Operates as an agricultural technology company that develops gene edited plant traits | Health Technology |
Australian National University
 Australian National University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Calgary
 University of Calgary Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Valigen NV
Valigen NV Miscellaneous Commercial ServicesCommercial Services Perform genotyping and functional genomics | Commercial Services |
Cibus US LLC
Cibus US LLC BiotechnologyHealth Technology Develops products in agriculture and specialty chemicals | Health Technology |
CSIRO's ICT Sector Advisory Council | |
Cibus, Inc.
 Cibus, Inc. Information Technology ServicesTechnology Services Operates as an agricultural technology company | Technology Services |
Cibus Ltd.
Cibus Ltd. BiotechnologyHealth Technology Engages in the research and development of plant gene editing technology | Health Technology |
